1,599
Views
22
CrossRef citations to date
0
Altmetric
Laboratory Study

Luteolin ameliorates colistin-induced nephrotoxicity in the rat models

, , , , , , & show all
Pages 1735-1740 | Received 28 May 2016, Accepted 20 Aug 2016, Published online: 20 Oct 2016

Figures & data

Table 1. Comparison of pretreatment and post-treatment serum creatinine levels.

Figure 1. Total histopathological scoring and BrdU DNA fragmentation scores between groups.

Figure 1. Total histopathological scoring and BrdU DNA fragmentation scores between groups.

Figure 2. Histopathologic findings. (A, H&E; ×200) This picture shows degenere-necrotic tubules (arrows) in Kolistin group. (B, H&E; ×400) High magnification, vacuolar degeneration (arrowhead) and tubular dilatation in tubules. (C, H&E; ×600) High magnification, necrotic tubules with prominent nucleoli. (D, H&E; ×400) This picture displays extensive cortical necrosis (grade 3) without glomerular damage in Kolistin group. (E, H&E; ×400) Decreased tubular damage (arrows) seen in Kolistin and Luteolin group. (F, H&E; ×200) Improved toxicity with minimal tubular damage seen in Luteolin group (compare to D).

Figure 2. Histopathologic findings. (A, H&E; ×200) This picture shows degenere-necrotic tubules (arrows) in Kolistin group. (B, H&E; ×400) High magnification, vacuolar degeneration (arrowhead) and tubular dilatation in tubules. (C, H&E; ×600) High magnification, necrotic tubules with prominent nucleoli. (D, H&E; ×400) This picture displays extensive cortical necrosis (grade 3) without glomerular damage in Kolistin group. (E, H&E; ×400) Decreased tubular damage (arrows) seen in Kolistin and Luteolin group. (F, H&E; ×200) Improved toxicity with minimal tubular damage seen in Luteolin group (compare to D).

Figure 3. Immuno-fluorescent findings: Insitu BrdU DNA fragmentation; (A) scarce apoptotic cells at the tubulus epithelium in the Control Group (orange; ×200). (B) (red; ×200). (C) (blue; ×200). (D) Apoptotic cells that display significant signal density at the tubulus epithelium in the Colistin Group (orange; ×200). (E) (red; ×200). (F) (blue; ×200). (G) Apoptotic cells that display sparse signal density at the tubulus epithelium in the Luteolin group (orange; ×200). (H) (red; ×200). (I) (blue; ×200). (J) Apoptotic cells that display sporadic intensive signal density at the tubulus epithelium in the Colistin Group + Luteolin Group (orange; ×200). (K) (red; ×200). (L) (blue; ×200).

Figure 3. Immuno-fluorescent findings: Insitu BrdU DNA fragmentation; (A) scarce apoptotic cells at the tubulus epithelium in the Control Group (orange; ×200). (B) (red; ×200). (C) (blue; ×200). (D) Apoptotic cells that display significant signal density at the tubulus epithelium in the Colistin Group (orange; ×200). (E) (red; ×200). (F) (blue; ×200). (G) Apoptotic cells that display sparse signal density at the tubulus epithelium in the Luteolin group (orange; ×200). (H) (red; ×200). (I) (blue; ×200). (J) Apoptotic cells that display sporadic intensive signal density at the tubulus epithelium in the Colistin Group + Luteolin Group (orange; ×200). (K) (red; ×200). (L) (blue; ×200).

Table 2. TUNEL results and renal histological damage scoring in all experimental groups.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.